This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The academic medical centers received three-star ratings in isolated coronary artery bypass grafting (CABG) and isolated mitral valve replacement and repair (MVRR) surgeries. The latest analysis of data for AVR surgery covers the same time frame and includes five participating surgeons. “The Maiorana, MBA, MSN, R.N.,
Many patients with symptoms of mitral regurgitation are not candidates for openheartsurgery due to their advanced age or competing comorbidities, nor are they candidates for the only alternative, the MitraClip device. It is one of only two New Jersey hospitals offering the trial to patients. Sable , M.D.,
This is really the first valve that can be delivered via catheter where previously open-heartsurgery was the only option for patients healthy enough to undergo the procedure,” said Brian O’Neill, M.D. director of Interventional and Structural Heart Research at Henry Ford Hospital.
Stone , Director of Academic Affairs for the Mount Sinai Health System and Professor of Medicine (Cardiology), and Population Health Science and Policy, at the Icahn School of Medicine at Mount Sinai (New York, USA) will be the Principal Investigator of the Pivotal study.
The Medtronic Evolut TAVR platform includes devices less invasive than traditional open-heartsurgery for the treatment of symptomatic severe aortic stenosis. “At Cohen , MD, MSc, Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation , Director of Academic Affairs at St.
In addition, the Center has been able to withstand the widely perceived “brain drain” in other sectors, through ensuring opportunities for surgeons to academically advance, conduct research, integrate new technology in practice, and sustain international collaborations.
In their haste to hyperventilate about MINOCA, the authors don’t highlight the high percentage of cardiac interventions that are needed in patients with conventional, common epicardial disease - 80% need a coronary stent and 10% need openheartsurgery.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
105 
Let's personalize your content